Please try another search
Index | Last | High | Low | Chg. | Chg. % | Time | ||
---|---|---|---|---|---|---|---|---|
Hang Seng CCI | 3,955.67 | 4,017.31 | 3,951.66 | -25.85 | -0.65% | 14/05 | ||
Hang Seng Comp I | 2,859.20 | 2,889.94 | 2,858.94 | -1.74 | -0.06% | 14/05 | ||
Hang Seng CMC | 3,781.73 | 3,823.83 | 3,777.91 | -8.18 | -0.22% | 14/05 | ||
HS Healthcare | 2,454.53 | 2,492.39 | 2,448.17 | +13.46 | +0.55% | 14/05 | ||
Hang Seng Healthcare | 7,870.63 | 7,991.28 | 7,849.62 | +44.45 | +0.57% | 14/05 | ||
HS Composite LargeCap & MidCap | 3,006.67 | 3,039.42 | 3,006.25 | -1.72 | -0.06% | 14/05 | ||
HS China Central SOEs | 2,763.43 | 2,801.81 | 2,761.88 | -28.31 | -1.01% | 14/05 | ||
HS Stock Connect Hong Kong | 2,844.29 | 2,875.94 | 2,844.29 | -7.76 | -0.27% | 14/05 | ||
HS Composite MidCap & SmallCap | 2,271.94 | 2,296.62 | 2,269.89 | -4.54 | -0.20% | 14/05 | ||
HS Large-Mid Cap | 2,512.14 | 2,540.07 | 2,512.05 | -2.39 | -0.10% | 14/05 | ||
HS SCHK ML CN Companies | 2,826.01 | 2,862.00 | 2,826.01 | -9.46 | -0.33% | 14/05 | ||
HS SCHK Innovative Drug Select | 1,301.06 | 1,329.54 | 1,297.39 | +3.37 | +0.26% | 14/05 | ||
HS Large-Mid Cap Quality Select | 2,962.36 | 2,994.60 | 2,961.41 | -3.50 | -0.12% | 14/05 | ||
HS Large-Mid Cap Value Select | 2,658.21 | 2,685.89 | 2,656.86 | -3.76 | -0.14% | 14/05 | ||
HS SCHK SOEs Select | 2,597.71 | 2,634.69 | 2,597.32 | -22.94 | -0.88% | 14/05 | ||
HS Large-Mid Cap Value Comprehensive | 2,636.95 | 2,665.14 | 2,636.01 | -4.52 | -0.17% | 14/05 | ||
HS Large-Mid Cap Low Size Select | 2,835.53 | 2,870.80 | 2,835.53 | -7.11 | -0.25% | 14/05 | ||
HS Large-Mid Cap Momentum Select | 3,220.59 | 3,245.73 | 3,217.51 | +4.84 | +0.15% | 14/05 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review